Russell Investments Group
TEVA icon

Russell Investments Group’s Teva Pharmaceuticals TEVA Stock Holding History

Russell Investments Group’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$14.4M Buy
427,444
+33,856
+9% +$1.13M 0.01% 881
2026
Q1 		$11.7M Buy
393,588
+17,297
+5% +$556K 0.01% 848
2025
Q4 		$11.8M Buy
376,291
+177,555
+89% +$4.37M 0.01% 831
2025
Q3 		$4.01M Buy
198,736
+9,649
+5% +$169K ﹤0.01% 1444
2025
Q2 		$3.17M Sell
189,087
-76,690
-29% -$1.24M ﹤0.01% 1475
2025
Q1 		$4.08M Buy
265,777
+61,330
+30% +$1.1M 0.01% 1274
2024
Q4 		$4.51M Buy
204,447
+51,601
+34% +$939K 0.01% 1225
2024
Q3 		$2.75M Sell
152,846
-37,609
-20% -$658K ﹤0.01% 1515
2024
Q2 		$3.09M Buy
190,455
+80,546
+73% +$1.24M 0.01% 1403
2024
Q1 		$1.55M Sell
109,909
-25,709
-19% -$324K ﹤0.01% 1781
2023
Q4 		$1.42M Sell
135,618
-42,068
-24% -$393K ﹤0.01% 1801
2023
Q3 		$1.81M Buy
177,686
+24,812
+16% +$231K ﹤0.01% 1604
2023
Q2 		$1.15M Sell
152,874
-59,856
-28% -$485K ﹤0.01% 1862
2023
Q1 		$1.88M Buy
212,730
+16,609
+8% +$164K ﹤0.01% 1623
2022
Q4 		$1.79M Buy
196,121
+47,180
+32% +$412K ﹤0.01% 1661
2022
Q3 		$1.2M Sell
148,941
-124,928
-46% -$1.1M ﹤0.01% 1845
2022
Q2 		$2.06M Sell
273,869
-31,460
-10% -$274K ﹤0.01% 1573
2022
Q1 		$2.86M Buy
305,329
+209,626
+219% +$1.75M 0.01% 1441
2021
Q4 		$763K Sell
95,703
-29,631
-24% -$267K ﹤0.01% 2288
2021
Q3 		$1.23M Buy
125,334
+19,556
+18% +$183K ﹤0.01% 2093
2021
Q2 		$1.05M Sell
105,778
-164,191
-61% -$1.74M ﹤0.01% 2286
2021
Q1 		$3.1M Buy
269,969
+32,282
+14% +$370K 0.01% 1621
2020
Q4 		$2.28M Buy
237,687
+115,541
+95% +$1.11M ﹤0.01% 1686
2020
Q3 		$1.08M Buy
122,146
+8,985
+8% +$95.1K ﹤0.01% 2035
2020
Q2 		$1.38M Buy
113,161
+70,911
+168% +$802K ﹤0.01% 1867
2020
Q1 		$361K Sell
42,250
-3,411
-7% -$34.9K ﹤0.01% 2317
2019
Q4 		$441K Sell
45,661
-21,001
-32% -$187K ﹤0.01% 2449
2019
Q3 		$462K Sell
66,662
-728,713
-92% -$5.58M ﹤0.01% 2319
2019
Q2 		$7.32M Sell
795,375
-503,285
-39% -$6.07M 0.01% 1033
2019
Q1 		$20.4M Buy
1,298,660
+73,735
+6% +$1.3M 0.04% 558
2018
Q4 		$18.9M Sell
1,224,925
-371,640
-23% -$7.62M 0.04% 524
2018
Q3 		$34.4M Sell
1,596,565
-30,548
-2% -$709K 0.07% 346
2018
Q2 		$39.6M Sell
1,627,113
-237,709
-13% -$4.85M 0.08% 264
2018
Q1 		$31.9M Buy
1,864,822
+103,730
+6% +$2.03M 0.05% 398
2017
Q4 		$33.5M Buy
1,761,092
+610,417
+53% +$9.18M 0.06% 406
2017
Q3 		$20.2M Sell
1,150,675
-1,525,488
-57% -$34.3M 0.03% 631
2017
Q2 		$88.9M Sell
2,676,163
-32,909
-1% -$1.02M 0.16% 132
2017
Q1 		$86.9M Buy
2,709,072
+11,644
+0.4% +$397K 0.16% 143
2016
Q4 		$97.3M Buy
+2,697,428
New +$108M 0.19% 119

Other funds holding TEVA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
HIIFS
Harel Insurance Investments & Financial Services Ramat Gan, Israel $20.6B AUM 59.59% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $25.6B AUM 50.04% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $15.6B AUM 71.29% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
LIM
Lingotto Investment Management London, United Kingdom $4.67B AUM 70.24% 1-Year Est. Return

Russell Investments Group's TEVA Position: Q2 2026 in Review

Russell Investments Group increased its Teva Pharmaceuticals (TEVA) stake by 8.6% in Q2 2026, buying an estimated $1.13M and bringing the position to 427,444 shares worth $14.4M. The position accounts for 0.01% of the portfolio, ranked #881.

Russell Investments Group first reported a position in TEVA in Q4 2016 and has held it in 39 quarters since. The position peaked at $97.3M in Q4 2016. 672 funds tracked by Wall St. Rank hold TEVA as of Q2 2026.

  • Russell Investments Group held 427,444 shares of Teva Pharmaceuticals worth $14.4M as of Q2 2026.
  • Russell Investments Group bought 33,856 Teva Pharmaceuticals shares in Q2 2026, an estimated $1.13M.
  • Teva Pharmaceuticals made up 0.01% of Russell Investments Group's portfolio in Q2 2026, its #881 holding.
  • Russell Investments Group first reported a position in Teva Pharmaceuticals in Q4 2016 and has held it in 39 quarters since.
  • Russell Investments Group's Teva Pharmaceuticals position peaked at $97.3M in Q4 2016.
  • 672 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q2 2026.

Based on Russell Investments Group's 13F filing for Q2 2026, filed 6 Aug 2026.